For decades, tissue heterogeneity represented a challenge for scientists wishing to study isolated cells or cell populations. Traditional methods of selective purification (e.g., MagAB) are compromised by tissue artifacts and contamination and limited by a minimum tissue-requirement volume. The application of laser capture microdissection (LCM) technology to facilitate selective sampling of individual cells or groups of cells from histological specimens is gaining popularity and is now an established method of procuring cells for many downstream RNA, DNA, and protein experiments (1) (2) (3) (4) (5) (6) (7) . Although groups have reported successful RNA extraction from formalin-fixed, paraffin-embedded tissue (8) , fresh frozen tissues (FFT) are recommended for optimal RNA recovery. However, manipulation of FFT can be extremely challenging, and RNA purity and yield are dependent on optimal tissue preparation.
Despite the increasing acceptance and application of LCM, there seems to be no consensus regarding tissue preparation prior to LCM. Literature review has indicated that variations in tissue preparation methods can compromise the quality of RNA by up to 75%. The objective of this study was to determine the effects of tissue manipulation on the quantity and quality of RNA by comparing available protocols and to define a tissue preparation process that facilitates optimal LCM without affecting RNA quality.
With the approval of our institutional review board, a mastectomy tissue specimen was obtained immediately after surgery, cut into blocks, washed briefly with ice-cold phosphatebuffered saline (PBS), pH 7.2, followed by ice-cold isotonic (0.25 mol/L) sucrose, embedded in optimum cutting temperature (OCT) compound, snapfrozen in liquid nitrogen, and stored at -80°C. To determine the specimen's baseline RNA quality, a core biopsy was taken from one FFT block and RNA was extracted (Stratagene Absolutely RNA ® Microprep kit). Four different hematoxylin and eosin (H&E)-based tissue preparation protocols that reported successful extraction of quality RNA from FFT were identified in the literature. These four protocols (protocols 2, 3, 5, and 6) were compared with an H&E-based protocol developed in our laboratory-protocol no. 4-which was optimized for minimal preparation time with adequate preservation of histomorphology and RNA integrity. In addition, in order to determine any potential RNA compromise from H&E staining, we included a methyl green (MG)-based protocol (protocol no. 1) ( The quality and quantity of isolated total RNA were assessed using the RNA 6000 Pico LabChip kit and the 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Five hundred fifty microliters RNA 6000 Pico gel matrix were placed on a spin filter, centrifuged at maximum speed for 10 s, and divided in 65-μL aliquots. To each aliquot, 1 μL RNA 6000 Pico dye was added, and the mixture was vortex mixed and centrifuged at maximum speed for 10 min. Using the priming solution, each aliquot was filled with gel-dye mix, conditioning solution, marker, 1 μL RNA 6000 ladder, and RNA samples, and was then vortex mixed for 1 min before being run on the Bioanalyzer. Both the 28s/18s rRNA subunit ratio and the RNA integrity number (RIN) were used to evaluate RNA integrity.
Comparing MG to H&E, H&E allowed for faster and more exact identification of cells of interest ( Figure  1 , A-F). Methodological differences between the various H&E protocols resulted in great variation in preservation of histomorphology (i.e., the When assessed for efficiency, protocol 4 allowed for optimal microdissection of the histological specimens. Variations in tissue preparation also affected both quality and quantity of RNA yield. The expected yield for each protocol was 0.35 μg RNA. The observed total RNA yield ranged from 28.3% to 97.1% of expected (0.10-0.34 μg) ( Table 2 ). The baseline RNA quality (i.e., prestaining) was 8.1. The RNA quality poststaining ranged from 2.3 to 7.9 with only three samples yielding RNA of adequate quality that could be used for downstream applications. The RNA isolated from the cells prepared using protocol 4 was of the highest quality and showed minimal degradation when compared with Overall, the protocol developed in our laboratory (protocol 4) was optimal. Sophisticated high-throughput RNA-based experiments, such as gene-expression microarrays, have significantly enhanced our knowledge of cancer biology, and we now appreciate that carcinogenesis is a complex, multi-step process with many distinct pathological stages associated with complex genetic, epigenetic, molecular, and biological events (9,10). The ultimate goal of advanced molecular analysis of cancer is to provide a comprehensive model that combines molecular and genetic analyses and should aim not only to explain the pathways in the progression of invasive disease, but also to define the relationships between histological variants in a manner that can be translated into practical clinical applications. The simultaneous evaluation of gene expression of multiple genes may prove to be a powerful clinical prognostic or predictive tool (11) (12) (13) , and these potential applications continue to fascinate and challenge clinical scientists. The accuracy of this microarray data, however, is determined by the specificity/purity of the input RNA. The fundamental advantage of LCM is that it allows separation of cells of interest that may constitute as little as 1% of the volume of the biopsy sample so that molecular analysis can be performed on pure populations. Since its inception, LCM has significantly improved the quality of downstream DNA, RNA, and protein-based studies. This study demonstrates how increased complexity of tissue manipulation affects the integrity of RNA extracted from microdissected cells, with variations in quality up to 3-fold, and defines a rapid (between 50%-80% faster than other methods) protocol that preserves and enhances the histomorphology of fresh frozen breast tissue-facilitating precise dissection of cells with minimal compromise of RNA quality.
We believe that our findings contribute to the current body of literature which strives to optimize the sensitivity of downstream applications of LCM, and that they are helpful to our colleagues working in the same field.
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